AI assistant
Sending…
RESEARCH FRONTIERS INC — Director's Dealing 2017
Jul 20, 2017
34569_dirs_2017-07-20_14110bdf-7312-48fe-84d9-3a07f83bb4df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESEARCH FRONTIERS INC (REFR)
CIK: 0000793524
Period of Report: 2017-07-19
Reporting Person: Kaganowicz Alexander (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-19 | Stock Option (right to buy) | $9.80 | P | 32378 | Acquired | 2017-12-02 | Common Stock (32378) | Direct |
| 2017-07-19 | Stock Option (right to buy) | $3.69 | P | 5200 | Acquired | 2019-12-31 | Common Stock (5200) | Direct |
| 2017-07-19 | Stock Option (right to buy) | $3.70 | P | 2586 | Acquired | 2023-12-31 | Common Stock (2586) | Direct |
| 2017-07-19 | Stock Option (right to buy) | $5.56 | P | 12057 | Acquired | 2023-12-30 | Common Stock (12057) | Direct |
| 2017-07-19 | Stock Option (right to buy) | $5.19 | P | 892 | Acquired | 2024-12-30 | Common Stock (892) | Direct |
| 2017-07-19 | Stock Option (right to buy) | $5.26 | P | 495 | Acquired | 2025-12-30 | Common Stock (495) | Direct |
Footnotes
F1: All options in Table II were purchased by the reporting person from the Estate of Robert L. Saxe for a total amount of $3,000. The allocated price for each option was not assigned.
More from RESEARCH FRONTIERS INC
Interim / Quarterly Report
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 30
Annual Report
2026
Mar 19
Annual Report
2026
Mar 5
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 17